Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients.

Prediction of successful allograft rejection retreatment with OKT3.

Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients.

Pseudorejection: factors mimicking rejection in renal allograft recipients.

Successful treatment of steroid-resistant double-lung allograft rejection with Orthoclone OKT3.

Developing renal allograft surveillance strategies - urinary biomarkers of cellular rejection.

OKT3 treatment of steroid-resistant rejection in pediatric liver transplant recipients.

Imaging-based diagnosis of acute renal allograft rejection.

Urinary cytodiagnosis of acute renal allograft rejection using the cytocentrifuge.

Oxidative tryptophan metabolism in renal allograft recipients: increased kynurenine synthesis is associated with inflammation and OKT3 therapy.

Cimetidine and renal-allograft rejection.

Early severe renal allograft rejection.

The cellular basis of allograft rejection.



Symptomatic lymphocele developing soon after acute renal allograft rejection: coincidental or causal connection?

Cellular and molecular mechanisms of allograft rejection.

Oral versus intravenous high-dose steroid treatment of renal allograft rejection. The big shot or not?

Echocardiographic indexes of allograft rejection in pediatric cardiac transplant recipients.

Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients.

67Ga citrate in renal allograft rejection.

Anti-B lymphocytotoxins in renal-allograft rejection.

Mycobacterial disease in renal allograft recipients.

Serum lipoprotein abnormalities in renal allograft recipients.

Myoglobinuria masquerading as acute rejection in a renal allograft recipient with recurrent post transplant diabetic nephropathy.

Suggest Documents

Prediction of successful allograft rejection retreatment with OKT3.

Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients.

Pseudorejection: factors mimicking rejection in renal allograft recipients.

Successful treatment of steroid-resistant double-lung allograft rejection with Orthoclone OKT3.

Developing renal allograft surveillance strategies - urinary biomarkers of cellular rejection.

OKT3 treatment of steroid-resistant rejection in pediatric liver transplant recipients.

Imaging-based diagnosis of acute renal allograft rejection.

Urinary cytodiagnosis of acute renal allograft rejection using the cytocentrifuge.

Oxidative tryptophan metabolism in renal allograft recipients: increased kynurenine synthesis is associated with inflammation and OKT3 therapy.

Cimetidine and renal-allograft rejection.

Early severe renal allograft rejection.

The cellular basis of allograft rejection.

Cimetidine and renal-allograft rejection.

Cimetidine and renal-allograft rejection.

Symptomatic lymphocele developing soon after acute renal allograft rejection: coincidental or causal connection?

Cellular and molecular mechanisms of allograft rejection.

Oral versus intravenous high-dose steroid treatment of renal allograft rejection. The big shot or not?

Echocardiographic indexes of allograft rejection in pediatric cardiac transplant recipients.

Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients.

67Ga citrate in renal allograft rejection.

Anti-B lymphocytotoxins in renal-allograft rejection.

Mycobacterial disease in renal allograft recipients.

Serum lipoprotein abnormalities in renal allograft recipients.

Myoglobinuria masquerading as acute rejection in a renal allograft recipient with recurrent post transplant diabetic nephropathy.

Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients.

Recommend Documents

Follow Us